Serina Therapeutics SER
NYSE SER
$2.70 +0.05 (+1.89%)
As of: Aug 21, 2026 · 2:31 PM EDT

Serina Therapeutics (SER) Assets (QoQ) (2019 - 2025)

Serina Therapeutics (SER) Assets (QoQ) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.81 Bn 130.96 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.07 Bn 78.08 Bn 3.93 Bn
3 Argenx Se 65.47 Bn 60.29 Bn 1.37 Bn
4 Moderna 55.64 Bn 50.50 Bn 52.00 Mn
5 BeOne Medicines 41.99 Bn 36.89 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.68 Bn 28.37 Bn 992.69 Mn
7 BioNTech SE 27.69 Bn 9.29 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.36 Bn 26.52 Bn -
10 Serina Therapeutics 44.24 Mn 21.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -44.00%
Sep 30, 2025 38.83%
Jun 30, 2025 32.83%
Mar 31, 2025 0.10%
Dec 31, 2024 -9.56%
Sep 30, 2024 -30.57%
Jun 30, 2024 -1.36%
Mar 31, 2024 21.05%
Dec 31, 2023 -26.55%
Sep 30, 2023 2,356.74%
Jun 30, 2023 0.00%
Mar 31, 2023 -84.67%
Dec 31, 2022 61.40%
Sep 30, 2022 -22.14%
Jun 30, 2022 -5.04%
Mar 31, 2022 -13.89%
Dec 31, 2021 29.95%
Sep 30, 2021 -4.49%
Jun 30, 2021 -19.59%
Mar 31, 2021 -19.49%